Cargando…

Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor

The heterogeneity of tumor cell mass and the plasticity of cancer cell phenotypes in solid tumors allow for the insurgence of resistant and metastatic cells, responsible for cancer patients’ clinical management’s main challenges. Among several factors that are responsible for increased cancer aggres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabelo, Izadora Lorrany Alves, Arnaud-Sampaio, Vanessa Fernandes, Adinolfi, Elena, Ulrich, Henning, Lameu, Claudiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305434/ https://www.ncbi.nlm.nih.gov/pubmed/34359950 http://dx.doi.org/10.3390/cells10071782

Ejemplares similares

P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
por: Arnaud-Sampaio, Vanessa Fernandes, et al.
Publicado: (2022)

The P2X7 Receptor: Central Hub of Brain Diseases
por: Andrejew, Roberta, et al.
Publicado: (2020)

Metabostemness: Metaboloepigenetic reprogramming of cancer stem-cell functions
por: Menendez, Javier A., et al.
Publicado: (2014)

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
por: Ribeiro, Deidiane Elisa, et al.
Publicado: (2020)

Metabostemness: A New Cancer Hallmark
por: Menendez, Javier A., et al.
Publicado: (2014)

Modulation of Mouse Embryonic Stem Cell Proliferation and Neural Differentiation by the P2X7 Receptor
por: Glaser, Talita, et al.
Publicado: (2014)

Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems
por: Guimarães, Lara M.F., et al.
Publicado: (2021)

Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells
por: Schneider, Gabriela, et al.
Publicado: (2015)

Aptamers: novelty tools for cancer biology
por: Pereira, Ricardo L., et al.
Publicado: (2018)

Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
por: Ulrich, Henning, et al.
Publicado: (2018)

P2X7 Receptor in Hematological Malignancies
por: De Marchi, Elena, et al.
Publicado: (2021)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

P2X7 Receptor Function in Bone-Related Cancer
por: Adinolfi, Elena, et al.
Publicado: (2012)

P2X7 Variants in Oncogenesis
por: Pegoraro, Anna, et al.
Publicado: (2021)

A bradykinin-potentiating peptide (BPP-10c) from Bothrops jararaca induces changes in seminiferous tubules
por: Gilio, Joyce M, et al.
Publicado: (2013)

P2X(7) receptor: Death or life?
por: Adinolfi, Elena, et al.
Publicado: (2005)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019)

Bothrops jararaca Peptide with Anti-Hypertensive Action Normalizes Endothelium Dysfunction Involved in Physiopathology of Preeclampsia
por: Benedetti, Gabriel, et al.
Publicado: (2011)

Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression
por: Pegoraro, Anna, et al.
Publicado: (2020)

The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk
por: Adinolfi, Elena, et al.
Publicado: (2023)

P2X7 Receptor Signaling in Stress and Depression
por: Ribeiro, Deidiane Elisa, et al.
Publicado: (2019)

A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice
por: De Marchi, Elena, et al.
Publicado: (2022)

A Regulator of Metabolic Reprogramming: MicroRNA Let-7
por: Jiang, Shuai
Publicado: (2019)

Role of P2X7 Receptors in Immune Responses During Neurodegeneration
por: Oliveira-Giacomelli, Ágatha, et al.
Publicado: (2021)

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
por: Ji, Xiangming, et al.
Publicado: (2018)

The P2X7 receptor is a key modulator of aerobic glycolysis
por: Amoroso, F, et al.
Publicado: (2012)

Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming
por: Xie, Yang, et al.
Publicado: (2016)

Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
por: Giuliani, Anna Lisa, et al.
Publicado: (2014)

Metabolic Reprogramming in Glioma
por: Strickland, Marie, et al.
Publicado: (2017)

P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
por: Lara, Romain, et al.
Publicado: (2020)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
por: De Marchi, Elena, et al.
Publicado: (2019)

Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases
por: Glaser, Talita, et al.
Publicado: (2021)

Eicosapentaenoic acid-rich oil supplementation activates PPAR-γ and delays skin wound healing in type 1 diabetic mice
por: Burger, Beatriz, et al.
Publicado: (2023)

Reactivation of the inactive X chromosome in development and reprogramming
por: Ohhata, Tatsuya, et al.
Publicado: (2012)

Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA
por: Serguienko, Anastassia, et al.
Publicado: (2014)

Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming
por: Duan, Shixin, et al.
Publicado: (2023)

UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
por: Esteves, Pauline, et al.
Publicado: (2014)

Metabolic Reprograming in Macrophage Polarization
por: Galván-Peña, Silvia, et al.
Publicado: (2014)

Metabolic Reprogramming in Thyroid Carcinoma
por: Coelho, Raquel Guimaraes, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eusbtqsvi6m8a7o8ve391dd71n